New strategy for COVID-19 vaccination: targeting the receptor

$ 20.50

4.8
(368)
In stock
Description

A closer look at Canada's homegrown COVID-19 vaccine candidates

Modern Paradigm Towards Potential Target Identification for Antiviral (SARS-nCoV-2) and Anticancer Lipopeptides: A Pharmacophore-Based Approach - AJMB: Volume 14, Issue 1, Year 2022 - AJMB

A critical overview of current progress for COVID-19: development

Study: Booster dose of mRNA COVID vaccine prompts strong T cell

Lipid-Based Poly(I:C) Adjuvants Strongly Enhance the Immunogenicity of SARS-CoV-2 Receptor-Binding Domain Vaccine

Recent insights for the emerging COVID-19: Drug discovery, therapeutic options and vaccine development - ScienceDirect

State of the CAR-T: Risk of Infections with Chimeric Antigen

Modern Paradigm Towards Potential Target Identification for Antiviral (SARS-nCoV-2) and Anticancer Lipopeptides: A Pharmacophore-Based Approach - AJMB: Volume 14, Issue 1, Year 2022 - AJMB

Next-generation antivirals: targeting COVID-19 - The Pharmaceutical Journal